Tax adjustments include the net tax expense/benefit from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. Table of Contents POLYONE CORPORATION 3 GAAP Financial Information Recast for DSS Divestiture Sales 759.6$ 838.7$ 821.1$ 754.4$ 3,173.8$ 828.7$ 841.5$ 806.1$ 741.7$ 3,218.0$ 754.0$ 775.5$ 729.2$ 665.4$ 2,924.1$ Cost of sales 598.6 657.1 661.4 657.0 2,574.1 660.2 674.2 644.1 602.7 2,581.2 589.9 599.6 564.2 518.9 2,272.6 Gross margin 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5 Selling and administrative 104.8 108.5 104.2 66.1 383.6 112.5 118.0 104.1 151.6 486.2 93.8 97.2 90.7 112.2 393.9 Income from equity affiliates and minority interest 0.1 - - 26.8 26.9 - - - - - - - - - - Operating income (loss) 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6 Interest expense, net (15.6) (16.6) (15.9) (15.2) (63.3) (15.5) (15.7) (15.4) (15.5) (62.1) (16.1) (16.2) (16.2) (15.5) (64.0) Premium on early extinguishment of debt (10.6) - (5.2) - (15.8) - - - - - - - - (16.4) (16.4) Other income (expense), net 1.5 (1.3) (1.5) - (1.3) (0.7) (0.4) (1.6) (1.4) (4.1) (0.6) (1.2) (1.7) 0.3 (3.2) Income (loss) before income taxes 31.6 55.2 32.9 42.9 162.6 39.8 33.2 40.9 (29.5) 84.4 53.6 61.3 56.4 2.7 174.0 Income tax (expense) benefit (10.8) (21.6) (13.4) (16.6) (62.4) (10.7) (2.6) (12.0) 15.6 (9.7) (23.3) 4.3 (8.8) 2.3 (25.5) Net income (loss) from continuing operations 20.8 33.6 19.5 26.3 100.2 29.1 30.6 28.9 (13.9) 74.7 30.3 65.6 47.6 5.0 148.5 Net (loss) income from discontinued operations, net of income taxes (5.7) 147.0 3.3 (2.1) 142.5 0.1 0.9 3.8 (1.1) 3.7 (0.1) 1.4 (3.1) (2.0) (3.8) Net income (loss) 15.1 180.6 22.8 24.2 242.7 29.2 31.5 32.7 (15.0) 78.4 30.2 67.0 44.5 3.0 144.7 Less: Non-controlling interest 0.2 0.3 0.2 0.4 1.1 0.2 0.2 - 0.4 0.8 - (0.2) - 0.1 (0.1) Net income (loss) attributable to PolyOne common shareholders 15.3$ 180.9$ 23.0$ 24.6$ 243.8$ 29.4$ 31.7$ 32.7$ (14.6)$ 79.2$ 30.2$ 66.8$ 44.5$ 3.1$ 144.6$ Earnings per share attributable to PolyOne common shareholders - Basic Continuing operations 0.23$ 0.35$ 0.21$ 0.28$ 1.06$ 0.31$ 0.33$ 0.32$ (0.15)$ 0.82$ 0.34$ 0.73$ 0.55$ 0.06$ 1.69$ Discontinued operations (0.06)$ 1.50$ 0.03$ (0.02)$ 1.49$ -$ 0.01$ 0.04$ (0.01)$ 0.04$ -$ 0.02$ (0.04)$ (0.02)$ (0.04)$ Total 0.17$ 1.85$ 0.24$ 0.26$ 2.55$ 0.31$ 0.34$ 0.36$ (0.16)$ 0.86$ 0.34$ 0.75$ 0.51$ 0.04$ 1.65$ Earnings per share attributable to PolyOne common shareholders - Diluted Continuing operations 0.22$ 0.34$ 0.20$ 0.27$ 1.05$ 0.31$ 0.33$ 0.31$ (0.15)$ 0.81$ 0.34$ 0.73$ 0.54$ 0.06$ 1.67$ Discontinued operations (0.06)$ 1.49$ 0.04$ (0.02)$ 1.48$ -$ 0.01$ 0.04$ (0.01)$ 0.04$ -$ 0.01$ (0.04)$ (0.02)$ (0.04)$ Total 0.16$ 1.83$ 0.24$ 0.25$ 2.53$ 0.31$ 0.34$ 0.35$ (0.16)$ 0.85$ 0.34$ 0.74$ 0.50$ 0.04$ 1.63$ Sales 738.5$ 758.2$ 746.6$ 694.8$ 2,938.1$ 796.7$ Cost of sales 561.9 576.3 580.5 542.3 2,261.0 614.4 Gross margin 176.6 181.9 166.1 152.5 677.1 182.3 Selling and administrative 106.2 100.1 94.1 90.4 390.8 98.3 Operating income 70.4 81.8 72.0 62.1 286.3 84.0 Interest expense, net (14.6) (14.6) (15.1) (15.4) (59.7) (14.6) Premium on early extinguishment of debt - (0.4) - - (0.4) (0.3) Other income (expense), net - 0.1 (0.1) 0.4 0.4 (1.1) Income before income taxes 55.8 66.9 56.8 47.1 226.6 68.0 Income tax expense (17.6) (16.8) (14.0) (12.0) (60.4) (19.7) Net income from continuing operations 38.2 50.1 42.8 35.1 166.2 48.3 Net income (loss) from discontinued operations, net of income taxes 0.8 (0.1) (0.5) (1.4) (1.2) (1.4) Net income 39.0 50.0 42.3 33.7 165.0 46.9 Less: Non-controlling interest 0.1 - - 0.1 0.2 - Net income attributable to PolyOne common shareholders 39.1$ 50.0$ 42.3$ 33.8$ 165.2$ 46.9$ Earnings per share attributable to PolyOne common shareholders - Basic Continuing operations 0.45$ 0.59$ 0.51$ 0.43$ 1.98$ 0.58$ Discontinued operations 0.01$ -$ (0.01)$ (0.02)$ (0.01)$ (0.01)$ Total 0.46$ 0.59$ 0.50$ 0.41$ 1.97$ 0.57$ Earnings per share attributable to PolyOne common shareholders - Diluted Continuing operations 0.45$ 0.59$ 0.51$ 0.42$ 1.96$ 0.58$ Discontinued operations 0.01$ -$ (0.01)$ (0.02)$ (0.01)$ (0.01)$ Total 0.46$ 0.59$ 0.50$ 0.40$ 1.95$ 0.57$ POLYONE CORPORATION 4 Adjusted Financial Information Recast for DSS Divestiture Sales 759.6$ 838.7$ 821.1$ 754.4$ 3,173.8$ 828.7$ 841.5$ 806.1$ 741.7$ 3,218.0$ 754.0$ 775.5$ 729.2$ 665.4$ 2,924.1$ Cost of sales 601.6 670.6 656.6 606.9 2,535.7 656.0 660.1 637.0 592.6 2,545.7 588.7 597.4 561.0 511.0 2,258.1 Gross margin 158.0 168.1 164.5 147.5 638.1 172.7 181.4 169.1 149.1 672.3 165.3 178.1 168.2 154.4 666.0 Selling and administrative 102.4 106.2 107.6 107.5 423.7 109.6 108.4 100.0 94.5 412.5 91.6 93.1 88.1 96.5 369.3 Operating income 55.6 61.9 56.9 40.0 214.4 63.1 73.0 69.1 54.6 259.8 73.7 85.0 80.1 57.9 296.7 Interest expense, net (13.7) (16.6) (15.9) (15.2) (61.4) (15.5) (15.7) (15.4) (15.5) (62.1) (16.1) (16.2) (16.2) (15.5) (64.0) Other income (expense), net 0.1 (1.3) (1.5) - (2.7) (0.7) (0.9) (1.7) (1.5) (4.8) (0.6) (1.2) (1.8) 0.3 (3.3) Income before income taxes 42.0 44.0 39.5 24.8 150.3 46.9 56.4 52.0 37.6 192.9 57.0 67.6 62.1 42.7 229.4 Income tax expense (14.2) (16.1) (13.5) (9.8) (53.6) (14.9) (18.3) (16.6) (12.0) (61.8) (18.8) (21.3) (19.4) (12.1) (71.6) Adjusted net income from continuing operations 27.8 27.9 26.0 15.0 96.7 32.0 38.1 35.4 25.6 131.1 38.2 46.3 42.7 30.6 157.8 Less: Non-controlling interest 0.2 0.3 0.2 0.4 1.1 0.2 0.2 - 0.4 0.8 - (0.2) - 0.1 (0.1) Adjusted net income attributable to PolyOne common shareholders - continuing operations 28.0$ 28.2$ 26.2$ 15.4$ 97.8$ 32.2$ 38.3$ 35.4$ 26.0$ 131.9$ 38.2$ 46.1$ 42.7$ 30.7$ 157.7$ Adjusted earnings per share attributable to PolyOne common shareholders - Diluted 0.30$ 0.28$ 0.27$ 0.15$ 1.01$ 0.34$ 0.41$ 0.38$ 0.28$ 1.41$ 0.43$ 0.51$ 0.48$ 0.36$ 1.78$ Sales 738.5$ 758.2$ 746.6$ 694.8$ 2,938.1$ 796.7$ Cost of sales 557.8 576.5 576.1 540.7 2,251.1 612.0 Gross margin 180.7 181.7 170.5 154.1 687.0 184.7 Selling and administrative 100.0 93.9 88.3 94.9 377.1 99.0 Operating income 80.7 87.8 82.2 59.2 309.9 85.7 Interest expense, net (14.6) (14.6) (15.1) (15.4) (59.7) (14.6) Other (expense) income, net (0.2) 0.2 (0.1) 0.3 0.2 (1.2) Income before income taxes 65.9 73.4 67.0 44.1 250.4 69.9 Income tax expense (21.0) (23.1) (20.7) (11.5) (76.3) (20.7) Adjusted net income from continuing operations 44.9 50.3 46.3 32.6 174.1 49.2 Less: Non-controlling interest 0.1 - - 0.1 0.2 - Adjusted net income attributable to PolyOne common shareholders - continuing operations 45.0$ 50.3$ 46.3$ 32.7$ 174.3$ 49.2$ Adjusted earnings per share attributable to PolyOne common shareholders - Diluted 0.53$ 0.59$ 0.55$ 0.39$ 2.06$ 0.59$ POLYONE CORPORATION 5 Business Segment and Data Recast for DSS Divestiture Sales: Color, Additives and Inks 205.3 229.4 219.0 198.6 852.3 219.6 228.7 212.0 190.5 850.8 208.5 217.4 199.9 184.9 810.7 Specialty Engineered Materials 152.9 158.8 157.6 146.2 615.5 157.4 157.8 145.8 137.3 598.3 141.9 139.7 136.0 125.2 542.8 Performance Products and Solutions 166.6 210.3 207.4 188.9 773.2 207.6 211.2 213.0 184.8 816.6 175.9 190.3 175.2 152.7 694.1 PolyOne Distribution 268.0 275.1 275.0 257.1 1,075.2 284.1 287.0 280.5 262.8 1,114.4 265.7 266.8 259.5 242.1 1,034.1 Corporate and Eliminations (33.2) (34.9) (37.9) (36.4) (142.4) (40.0) (43.2) (45.2) (33.7) (162.1) (38.0) (38.7) (41.4) (39.5) (157.6) Sales 759.6 838.7 821.1 754.4 3,173.8 828.7 841.5 806.1 741.7 3,218.0 754.0 775.5 729.2 665.4 2,924.1 Gross Margin: Color, Additives and Inks 67.7 75.2 71.8 63.1 277.8 74.9 81.7 71.8 65.1 293.5 73.4 80.0 73.4 67.0 293.8 Specialty Engineered Materials 39.2 39.0 39.2 35.8 153.2 42.6 43.5 39.7 37.4 163.2 43.0 41.1 39.6 37.3 161.0 Performance Products and Solutions 24.0 26.9 27.6 23.5 102.0 28.0 29.0 29.2 22.8 109.0 22.5 27.4 27.2 24.8 101.9 PolyOne Distribution 28.2 28.1 27.6 24.7 108.6 29.8 28.8 29.3 26.1 114.0 27.8 30.2 29.4 27.2 114.6 Corporate and Eliminations 1.9 12.4 (6.5) (49.7) (41.9) (6.8) (15.7) (8.0) (12.4) (42.9) (2.6) (2.8) (4.6) (9.8) (19.8) Gross Margin 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5 Selling and Administrative Expense: Color, Additives and Inks 43.5 44.3 42.9 43.1 173.8 44.5 44.0 41.7 38.4 168.6 39.6 40.4 38.9 39.5 158.4 Specialty Engineered Materials 23.4 24.0 24.6 24.0 96.0 24.3 24.6 21.3 20.6 90.8 19.9 21.0 19.6 20.9 81.4 Performance Products and Solutions 10.4 11.6 12.5 11.5 46.0 12.0 11.4 11.4 11.1 45.9 11.0 11.1 11.1 11.3 44.5 PolyOne Distribution 12.0 11.2 11.0 11.1 45.3 12.6 11.5 10.6 11.1 45.8 12.1 11.1 11.8 11.6 46.6 Corporate and Eliminations 15.5 17.4 13.2 (23.6) 22.5 19.1 26.5 19.1 70.4 135.1 11.2 13.6 9.3 28.9 63.0 Selling and Administrative Expense 104.8 108.5 104.2 66.1 383.6 112.5 118.0 104.1 151.6 486.2 93.8 97.2 90.7 112.2 393.9 Operating Income: Color, Additives and Inks 24.2 30.9 28.9 20.0 104.0 30.4 37.7 30.1 26.7 124.9 33.8 39.6 34.5 27.5 135.4 Specialty Engineered Materials 15.8 15.0 14.6 11.8 57.2 18.3 18.9 18.4 16.8 72.4 23.1 20.1 20.0 16.4 79.6 Performance Products and Solutions 13.6 15.3 15.1 12.0 56.0 16.0 17.6 17.8 11.7 63.1 11.5 16.3 16.1 13.5 57.4 PolyOne Distribution 16.2 16.9 16.6 13.6 63.3 17.2 17.3 18.7 15.0 68.2 15.7 19.1 17.6 15.6 68.0 Corporate and Eliminations (13.5) (5.0) (19.7) 0.7 (37.5) (25.9) (42.2) (27.1) (82.8) (178.0) (13.8) (16.4) (13.9) (38.7) (82.8) Operating Income (loss) 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6 Sales: Color, Additives and Inks 204.9 212.2 195.9 184.7 797.7 211.8 Specialty Engineered Materials 141.0 143.3 146.2 135.3 565.8 159.1 Performance Products and Solutions 166.2 172.8 171.3 158.2 668.5 183.7 PolyOne Distribution 268.8 272.6 274.8 254.8 1,071.0 286.1 Corporate and Eliminations (42.4) (42.7) (41.6) (38.2) (164.9) (44.0) Sales 738.5 758.2 746.6 694.8 2,938.1 796.7 Gross Margin: Color, Additives and Inks 75.3 78.0 70.0 62.8 286.1 75.2 Specialty Engineered Materials 44.2 43.0 41.7 38.6 167.5 46.1 Performance Products and Solutions 32.4 33.0 29.2 26.6 121.2 33.9 PolyOne Distribution 30.7 29.5 29.6 27.3 117.1 31.4 Corporate and Eliminations (6.0) (1.6) (4.4) (2.8) (14.8) (4.3) Gross Margin 176.6 181.9 166.1 152.5 677.1 182.3 Selling and Administrative Expense: Color, Additives and Inks 40.4 39.8 38.6 39.8 158.6 40.1 Specialty Engineered Materials 20.8 21.6 21.2 22.8 86.4 22.5 Performance Products and Solutions 12.7 11.7 11.2 11.2 46.8 11.8 PolyOne Distribution 13.2 11.7 11.4 12.6 48.9 12.8 Corporate and Eliminations 19.1 15.3 11.7 4.0 50.1 11.1 Selling and Administrative Expense 106.2 100.1 94.1 90.4 390.8 98.3 Operating Income: Color, Additives and Inks 34.9 38.2 31.4 23.0 127.5 35.1 Specialty Engineered Materials 23.4 21.4 20.5 15.8 81.1 23.6 Performance Products and Solutions 19.7 21.3 18.0 15.4 74.4 22.1 PolyOne Distribution 17.5 17.8 18.2 14.7 68.2 18.6 Corporate and Eliminations (25.1) (16.9) (16.1) (6.8) (64.9) (15.4) Operating Income 70.4 81.8 72.0 62.1 286.3 84.0 POLYONE CORPORATION 6 Non-GAAP Reconciliations Sales 759.6 838.7 821.1 754.4 3,173.8 828.7 841.5 806.1 741.7 3,218.0 754.0 775.5 729.2 665.4 2,924.1 Gross margin - GAAP 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5 Special items in gross margin (see slide 7) (3.0) (13.5) 4.8 50.1 38.4 4.2 14.1 7.1 10.1 35.5 1.2 2.2 3.2 7.9 14.5 Adjusted gross margin 158.0 168.1 164.5 147.5 638.1 172.7 181.4 169.1 149.1 672.3 165.3 178.1 168.2 154.4 666.0 Adjusted gross margin as a percent of sales 20.8% 20.0% 20.0% 19.6% 20.1% 20.8% 21.6% 21.0% 20.1% 20.9% 21.9% 23.0% 23.1% 23.2% 22.8% Operating income - GAAP 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6 Special items in operating income (see slide 7) (0.7) (11.2) 1.4 (18.1) (28.6) 7.1 23.7 11.2 67.2 109.2 3.4 6.3 5.8 23.6 39.1 Adjusted operating income 55.6 61.9 56.9 40.0 214.4 63.1 73.0 69.1 54.6 259.8 73.7 85.0 80.1 57.9 296.7 Adjusted operating income as a percent of sales 7.3% 7.4% 6.9% 5.3% 6.8% 7.6% 8.7% 8.6% 7.4% 8.1% 9.8% 11.0% 11.0% 8.7% 10.1% Sales 738.5 758.2 746.6 694.8 2,938.1 796.7 Gross margin - GAAP 176.6 181.9 166.1 152.5 677.1 182.3 Special items in gross margin (see slide 7) 4.1 (0.2) 4.4 1.6 9.9 2.4 Adjusted gross margin 180.7 181.7 170.5 154.1 687.0 184.7 Adjusted gross margin as a percent of sales 24.5% 24.0% 22.8% 22.2% 23.4% 23.2% Operating income - GAAP 70.4 81.8 72.0 62.1 286.3 84.0 Special items in operating income (see slide 7) 10.3 6.0 10.2 (2.9) 23.6 1.7 Adjusted operating income 80.7 87.8 82.2 59.2 309.9 85.7 Adjusted operating income as a percent of sales 10.9% 11.6% 11.0% 8.5% 10.5% 10.8% POLYONE CORPORATION 7 Summary of Special Items Cost of sales: Restructuring Costs - - - (2.5) (2.5) (3.3) (13.2) (2.8) (7.4) (26.7) (0.2) (0.2) (1.0) (6.3) (7.7) Environmental remediation costs (2.0) (1.3) (4.8) (52.6) (60.7) (0.9) (0.9) (5.9) (2.6) (10.3) (1.5) (2.0) (4.3) (1.5) (9.3) Pension & other post-retirement benefits - mark-to-market adjustment - - - 1.6 1.6 - - - (2.0) (2.0) - - - (1.0) (1.0) Reimbursement of previously incurred environmental costs 5.2 14.9 - 3.4 23.5 - - 1.6 2.1 3.7 0.5 - 2.1 0.9 3.5 Acquisition related adjustments (0.2) (0.1) - - (0.3) - - - (0.2) (0.2) - - - - - Impact on cost of sales 3.0 13.5 (4.8) (50.1) (38.4) (4.2) (14.1) (7.1) (10.1) (35.5) (1.2) (2.2) (3.2) (7.9) (14.5) Selling and administrative expense: Restructuring, legal and other (2.3) (1.9) 4.1 (1.0) (1.1) (2.7) (9.3) (3.9) 1.0 (14.9) (1.9) (3.4) (1.8) (3.9) (11.0) Unrealized gain on foreign currency option contracts 0.4 0.2 0.3 0.2 1.1 - - - - - - - - - - Pension & other post-retirement benefits - mark-to-market adjustment - - 42.4 42.4 - - - (54.5) (54.5) - - - (10.6) (10.6) Acquisition/divestiture related costs (0.5) (0.6) (1.0) (0.2) (2.3) (0.2) (0.3) (0.2) (3.6) (4.3) (0.3) (0.7) (0.8) (1.2) (3.0) Impact on selling and administrative expense (2.4) (2.3) 3.4 41.4 40.1 (2.9) (9.6) (4.1) (57.1) (73.7) (2.2) (4.1) (2.6) (15.7) (24.6) Gain on sale of investment in equity affiliates 0.1 - - 26.8 26.9 - - - - - - - - - - Impact on operating income 0.7 11.2 (1.4) 18.1 28.6 (7.1) (23.7) (11.2) (67.2) (109.2) (3.4) (6.3) (5.8) (23.6) (39.1) - - - Debt extinguishment costs (10.6) - (5.2) - (15.8) - - - - - - - - (16.4) (16.4) Bridge loan commitment fees - interest expense (1.9) - - - (1.9) - - - - - - - - - - Other income (expense), net 1.4 - - - 1.4 - 0.5 0.1 0.1 0.7 - - 0.1 - 0.1 Impact on income before income taxes (10.4) 11.2 (6.6) 18.1 12.3 (7.1) (23.2) (11.1) (67.1) (108.5) (3.4) (6.3) (5.7) (40.0) (55.4) Income tax benefit on above special items 3.9 (5.3) 1.9 (7.1) (6.6) 2.6 10.5 4.5 24.0 41.6 1.4 1.7 1.0 14.6 18.7 Tax adjustments (0.5) (0.2) (1.8) 0.3 (2.2) 1.6 5.2 0.1 3.6 10.5 (5.9) 23.9 9.6 (0.2) 27.4 Impact of special items on net income (7.0) 5.7 (6.5) 11.3 3.5 (2.9) (7.5) (6.5) (39.5) (56.4) (7.9) 19.3 4.9 (25.6) (9.3) Diluted earnings per common share impact (0.08)$ 0.06$ (0.07)$ 0.12$ 0.04$ (0.03)$ (0.08)$ (0.07)$ (0.43)$ (0.60)$ (0.09)$ 0.22$ 0.06$ (0.30)$ (0.11)$ Cost of sales: Restructuring Costs 0.1 (1.0) - (0.2) (1.1) - Environmental remediation costs (1.7) (2.1) (2.4) (2.2) (8.4) (2.2) Pension & other post-retirement benefits - mark-to-market adjustment - - - 0.3 0.3 - Reimbursement of previously incurred environmental costs - 5.3 - 0.8 6.1 - Acquisition related adjustments (2.5) (2.0) (2.0) (0.3) (6.8) (0.2) Impact on cost of sales (4.1) 0.2 (4.4) (1.6) (9.9) (2.4) Selling and administrative expense: Restructuring, legal and other (5.9) (5.6) (5.3) (3.0) (19.8) 1.4 Unrealized gain on foreign currency option contracts - - - - - - Pension & other post-retirement benefits - mark-to-market adjustment - - - 8.1 8.1 - Acquisition/divestiture related costs (0.3) (0.6) (0.5) (0.6) (2.0) (0.7) Impact on selling and administrative expense (6.2) (6.2) (5.8) 4.5 (13.7) 0.7 Gain on sale of investment in equity affiliates - - - - - - Impact on operating income (10.3) (6.0) (10.2) 2.9 (23.6) (1.7) Debt extinguishment costs - (0.4) - - (0.4) (0.3) Bridge loan commitment fees - interest expense - - - - - - Other income (expense), net 0.2 (0.1) - 0.1 0.2 0.1 Impact on income before income taxes (10.1) (6.5) (10.2) 3.0 (23.8) (1.9) Income tax benefit on above special items 3.8 2.6 3.7 (1.8) 8.3 0.9 Tax adjustments (0.4) 3.7 3.0 1.3 7.6 0.1 Impact of special items on net income (6.7) (0.2) (3.5) 2.5 (7.9) (0.9) Diluted earnings per common share impact (0.08)$ -$ (0.04)$ 0.03$ (0.10)$ (0.01)$ Recast Financial Information for Discontinued Operations Table of Contents GAAP Financial Information Recast for DSS Divestiture Adjusted Financial Information Recast for DSS Divestiture Business Segment and Data Recast for DSS Divestiture Non-GAAP Reconciliations Summary of Special Items

Taxes, Fees, and Duties. Seller’s invoices will include value added tax (or equivalent or similar taxes), and such taxes shall be a separate line item on the invoice. Unless otherwise expressly agreed in writing between the Buyer and the Seller, the purchase price for the Product shall be exclusive of any value added tax (or equivalent or similar taxes) and the Buyer shall pay the Seller the amount of value added tax (or equivalent or similar taxes) chargeable on the supply of the Product in addition to the purchase price.

Reconciliation to condensed $ Millions EPS (in $) $ Millions EPS (in $) Net (loss) income attributable to Avient common shareholders (20.2) (0.22) 49.4 0.54 Special items, after-tax 75.7 0.82 5.5 0.06 Amortization expense, after-tax 14.5 0.16 14.9 0.16 Adjusted net income / EPS 70.0 0.76 69.8 0.76 Per share amounts may not recalculate from figures present herein due to rounding 11 Reconciliation to EBITDA and Adjusted EBITDA $ Millions $ Millions Net (loss) income – GAAP (19.9) 49.7 Income tax (benefit) expense (6.7) 16.8 Interest expense, net 26.9 26.6 Depreciation & amortization 45.3 44.3 EBITDA 45.6 137.4 Special items, before tax 101.2 6.2 Interest expense included in special items (1.7) - Depreciation & amortization included in special items (0.4) (0.5) Adjusted EBITDA 144.7 143.1 Adjusted EBITDA as a percent of sales 17.5% 17.3% PAGE 1 OF 3 Copyright © . 2025 30 Reconciliation of Non-GAAP financial measures Reconciliation to EBITDA and Adjusted EBITDA $ Millions $ Millions Sales Color, Additives and Inks 519.7 515.3 Specialty Engineered Materials 308.4 314.4 Corporate (1.5) (0.7) Sales 826.6 829.0 Operating income Color, Additives and Inks 78.6 74.8 Specialty Engineered Materials 47.1 53.4 Corporate (125.0) (34.2) Operating income 0.7 94.0 Depreciation and amortization Color, Additives and Inks 21.7 21.9 Specialty Engineered Materials 21.5 19.6 Corporate 2.1 2.8 Depreciation and amortization 45.3 44.3 Earnings before interest, taxes, depreciation and amortization Color, Additives and Inks 100.3 96.7 Specialty Engineered Materials 68.6 73.0 Corporate (122.9) (31.4) Other expense, net (0.4) (0.9) EBITDA 45.6 137.4 Special items, before tax 101.2 6.2 Interest expense included in special items (1.7) - Depreciation and amortization included in special items (0.4) (0.5) Adjusted EBITDA 144.7 143.1 Adjusted EBITDA as a percent of sales Color, Additives and Inks 19.3% 18.8% Specialty Engineered Materials 22.2% 23.2% PAGE 2 OF 3 Copyright © . 2025 31 measures Reconciliation to condensed Three months ended March 31, 2023 $ Millions EPS (in $) Net income from continuing operations attributable to Avient common shareholders 20.8 0.23 Special items, after-tax 22.3 0.24 Amortization expense, after-tax 15.1 0.16 Adjusted net income / EPS 58.2 0.63 Reconciliation to EBITDA and Adjusted EBITDA Year ended December 31, 2024 $ Millions Net income – GAAP 170.7 Income tax expense 54.1 Interest expense 105.6 Depreciation & amortization 179.7 EBITDA 510.1 Special items, before tax 20.1 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.5) Adjusted EBITDA 526.4 Adjusted EBITDA as a percent of sales 16.2% PAGE 3 OF 3 Reconciliation to condensed Three months ended June 30, 2024 $ Millions EPS (in $) Net income attributable to Avient common shareholders 33.6 0.36 Special items, after-tax 21.8 0.24 Amortization expense, after-tax 14.8 0.16 Adjusted net income / EPS 70.2 0.76 Reconciliation to condensed Year ended December 31, 2024 $ Millions EPS (in $) Net (loss) income attributable to Avient common shareholders 169.5 1.84 Special items, after-tax 15.9 0.17 Amortization expense, after-tax 59.5 0.65 Adjusted net income / EPS 244.9 2.66 Per share amounts may not recalculate from figures present herein due to rounding Q4 2024 Earnings webcast Slide 1 Slide 2: Disclaimer Slide 3: Avient at a glance...

https://www.avient.com/sites/default/files/resources/CCG%2520Food%2520Handling%2520Case%2520Study%2520FINAL%2520PDF.pdf https://www.avient.com/sites/default/files/resources/CCG%2520Food%2520Handling%2520Case%2520Study%2520FINAL%2520PDF.pdf Source: https://www.engineering.com/3DPrinting/3DPrintingArticles/ArticleID/14465/3D- Printing-Filaments-Whats-the-Deal-with-ULTEM-and-PEEK.aspx High-performance thermoplastics can be processed using injection molding, compression molding, and extrusion. Source: https://pbipolymer.com/ https://www.engineering.com/3DPrinting/3DPrintingArticles/ArticleID/14465/3D-Printing-Filam https://www.engineering.com/3DPrinting/3DPrintingArticles/ArticleID/14465/3D-Printing-Filam https://pbipolymer.com/ Source: https://www.solvay.com/sites/g/files/srpend221/files/2018-11/Additive-Manufacturing-Filaments-Processing-Guide_EN-v1.1_0.pdf BRASS OR STEEL DIE? https://www.solvay.com/sites/g/files/srpend221/files/2018-11/Additive-Manufacturing-Filaments-Processing-Guide_EN-v1.1_0.pdf High-temperature polymer formulations provide robust material performance at elevated temperatures, even those in excess of 300°F (150°C).

KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.

MEVOPUR COLORANTS • Standard colors in PP and PE to shorten time-to-market • Custom colors matched to Pantone, RAL or other color reference • White colorants for pharmaceutical packaging for LDPE, HDPE and PP with opacity to reach USP chapter MEVOPUR FUNCTIONAL ADDITIVES • Antistatic formulation with good flow/impact for injection molding • Amide- and amine-free antistatic for film in contact with API (Active Pharmaceutical Ingredients) • UV blocking for transparent PP and PE packaging to meet USP chapter • Non-migrating friction reduction/processing aid for PE and PP • Laser marking/welding additive for fast, reliable marking/assembly • MVTR (Moisture Vapor Transmission Rate) reduction for HDPE to improve shelf-life • Thermal protection of the polymer during processing • Gamma/e-beam sterilization protection for PP (up to 50kGy) with color compensation for reduced yellowing REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Bormed™ is a registered trademark of Borealis Healthcare use limitations apply—see below.

REGULATORY SUPPORT • Drug delivery devices • Pharmaceutical packaging • Medical equipment KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing the risk of change • Allows crystallization in semi-crystalline polymers to begin faster and complete earlier REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Healthcare use limitations apply—see below.

KEY CHARACTERISTICS • Formulated specifically for healthcare product applications • Wide portfolio of polymer additive solutions, including: - Antimicrobial technology - Surface energy modification, including low retention - Authentication technology - Lasermarking - Sterilization and content protection - Processing optimization - FDA compliant resin and color changeover solutions • OnCap HC Plus certified for USP Class VI and ISO 10993 bio-compatibility requirements; includes anti-oxidant, lasermarking, antimicrobial, radiopacifier, anti-stat, and polymer and gamma stabilization performance additives OnCap™ HC & OnCap™ HC Plus Additives for Healthcare PRODUCT BULLETIN INDUSTRY SUPPORT • Supported with a broad range of technical support and services: - Restricted medical-grade raw material selection process - Sampling program - World-class FDA cGMP manufacturing facilities - Batch traceability and formulation lockdown systems - FDA Drug Master Files or Medical Device Files maintenance MARKETS AND APPLICATIONS OnCap HC and OnCap HC Plus Additives are an excellent choice for medical devices and parts, pharmaceutical or cosmetic packaging, and many other healthcare related polymer applications.

Corporate seat Amsterdam First entry in Business Register 12-04-2006 Date of deed of incorporation 11-04-2006 Date of deed of last amendment to the Articles of Association 12-04-2021 Issued capital EUR 19.593,63 Paid-up capital EUR 19.593,63 Filing of the annual accounts The annual accounts for the financial year 2019 were filed on 01-07-2020.

Platform operating income mix percentage 2005Y 2008Y 2011Y Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 45.9 Global Color, Additives and Inks 4.3 28.1 43.4 Specialty Platform $ 4.7 $ 45.7 $ 89.3 Performance Products and Solutions 75.7 31.3 62.4 Distribution 19.5 28.1 56.0 SunBelt Joint Venture 91.9 28.6 5.0 Corporate (51.5) (425.1) 20.3 Operating income (loss) GAAP $ 140.3 $ (291.4) $ 233.0 Less: Corporate operating expense (income) 51.5 425.1 (20.3) Operating income excluding Corporate $ 191.8 $ 133.7 $ 212.7 Specialty platform operating mix percentage 2% 34% 42% Pro forma platform operating income mix percentage 2007 Pro forma 2011Y Specialty Platform $ 30.6 $ 89.3 Pro forma ColorMatrix - 27.7 Specialty Platform pro forma ColorMatrix $ 30.6 $ 117.0 Performance Products and Solutions 65.8 62.4 Distribution 22.1 56.0 SunBelt Joint Venture 34.8 5.0 Corporate (73.3) 20.3 Operating income pro forma ColorMatrix $ 80.0 $ 260.7 Less: Corporate and SunBelt operating income 73.3 (25.3) Operating income excluding Corporate operating income $ 153.3 $ 235.4 Specialty platform operating mix percentage 20% 50% Adjusted EPS 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y Net Income $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 162.6 $ 172.6 SunBelt and OxyVinyls equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 75.4 $ 96.1 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.79 $ 1.02 Adjusted EPS Q1 2011 Q1 2012 Net Income $ 110.2 $ 20.2 SunBelt equity earnings, after tax (3.7) - Special items, after tax (79.8) 6.1 Tax adjustments (1.5) 0.1 Adjusted net income $ 25.2 $ 26.4 Diluted shares 96.4 90.7 Adjusted EPS $ 0.26 $ 0.29 Platform sales and operating income (OI) 2005 2006 2007 2008 2009 2010 2011 Global Specialty Engineered Materials Sales $ 282.5 $ 345.3 $ 384.4 $ 514.0 $ 402.9 $ 517.4 $ 575.1 Global Color, Additives and Inks Sales 503.7 531.8 560.5 554.3 459.8 527.4 544.6 Specialty Platform Sales $ 786.2 $ 877.1 $ 944.9 $ 1,068.3 $ 862.7 $ 1,044.8 $ 1,119.7 Performance Products and Solutions Sales 1,136.3 1,166.2 1,086.8 1,001.4 667.7 776.3 865.4 PolyOne Distribution Sales 679.2 732.8 744.3 796.7 625.1 911.9 996.5 Corporate and Eliminations (151.1) (153.7) (133.3) (127.7) (94.8) (111.1) (118.1) Total Sales $ 2,450.6 $ 2,622.4 $ 2,642.7 $ 2,738.7 $ 2,060.7 $ 2,621.9 $ 2,863.5 Pro forma ColorMatrix Sales 196.0 Total sales pro forma ColorMatrix $ 3,059.5 Global Specialty Engineered Materials OI $ 0.4 $ 3.9 $ 4.9 $ 17.6 $ 20.6 $ 49.7 $ 45.9 Global Color, Additives and Inks OI 4.3 8.9 25.7 28.1 25.2 37.7 43.4 Specialty Platform OI $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 89.3 Performance Products and Solutions OI 75.7 64.2 65.8 31.3 33.1 54.0 62.4 PolyOne Distribution OI 19.5 19.2 22.1 28.1 24.8 42.0 56.0 Sunbelt Joint Venture OI 91.9 102.9 34.8 28.6 25.5 18.9 5.0 Corporate and eliminations (21.8) (4.6) (25.5) (28.9) (40.8) (32.5) (26.4) Special items (29.7) 39.1 (47.8) (396.2) 48.7 4.8 46.7 Operating income (loss) GAAP $ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 233.0 Sunbelt equity income (72.5) (107.0) (40.8) (32.5) (29.7) (23.1) (5.7) Special items 29.7 (39.1) 47.8 396.2 (48.7) (4.8) (46.7) Operating income adjusted $ 97.5 $ 87.5 $ 87.0 $ 72.3 $ 58.7 $ 146.7 $ 180.6 Operating income pro forma ColorMatrix 27.7 Operating income adjusted pro forma ColorMatrix $ 208.3 Global Specialty Engineered Materials - OI as a percentage of sales 0.1% 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% Global Color, Additives and Inks - OI as a percentage of sales 0.9% 1.7% 4.6% 5.1% 5.5% 7.1% 8.0% Specialty platform OI as a percentage of sales 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% Specialty platform OI as a percentage of sales - pro forma ColorMatrix 8.9% Global Color, Additives and Inks OI as a percentage of sales – pro forma ColorMatrix 9.6% PP&S operating OI as a percentage of sales 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% Distribution OI as a percentage of sales 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% PolyOne OI adjusted, as a percentage of sales 4.0% 3.3% 3.3% 2.6% 2.8% 5.6% 6.3% PolyOne OI adjusted, pro forma for ColorMatrix, as a percent of sales 6.8% Operating income (OI) Q1 2011 Q1 2012 Global Specialty Engineered Materials OI $ 14.0 $ 11.8 Global Color, Additives and Inks OI 11.2 17.3 Specialty Platform OI $ 25.2 $ 29.1 Performance Products and Solutions OI 14.3 17.8 PolyOne Distribution OI 14.7 16.7 Corporate and eliminations (1.6) (10.2) Special items 127.2 (8.5) Operating income (loss) GAAP $ 179.8 $ 44.9 Research and Development (R&D) – Pro forma ColorMatrix 2011 PolyOne R&D $ 36.9 ColorMatrix R&D 3.6 Pro forma R&D $ 40.5 Gross Margin as a percentage of Sales 2006 2011 2011 Pro forma ColorMatrix Specialty platform sales $ 877.1 $ 1,119.7 $ 1,315.7 Specialty platform gross margin 125.2 263.4 345.9 Specialty platform gross margin percentage 14.3 % 23.5 % 26.3 % Average Debt Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne Debt $ 452.9 $ 432.9 $ 432.9 $ 432.9 $ 707.0 n/a Pro forma ColorMatrix 274.1 274.1 274.1 274.1 - n/a Total Debt $ 727.0 $ 707.0 $ 707.0 $ 707.0 $ 707.0 $ 711.0 Average Equity Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne $ 516.0 $ 615.2 $ 629.6 $ 608.5 $ 588.3 $ 591.5